37 unchanged sentences
Number Description Form Exhibit Filing Date
−Removed: Agreement and Plan of Merger, dated as of August 7, 2017, by and among the Registrant, Galena Bermuda Merger Sub, Ltd., Sellas Intermediate Holdings I, Inc., Sellas Intermediate Holdings II, Inc.
−Removed: and SELLAS Life Sciences Group Ltd, as amended (included as Annex A to the proxy statement/prospectus/consent solicitation statement).
−Removed: 8-K 2.1 August 8, 2017
3.1 Composite Amended and Restated Certificate of Incorporation of the Registrant (formerly, Galena Biopharma, Inc.), amended as of December 27, 2017.
12 unchanged sentences
10-K 10.2 March 28, 2012
−Removed: 4.4 Form of Warrant in connection with January Registered Direct 2020.
−Removed: 8-K 4.1 January 10, 2020
−Removed: 4.5 Form of Pre-Funded Warrant in connection with January registered Direct 2020 Offering.
−Removed: 8-K 4.2 January 10, 2020
−Removed: 4.6 Form of Warrant in connection with July 2020 Private Placement.
−Removed: 8-K 4.1 August 4, 2020
4.4 Form of Warrant.
4 unchanged sentences
8-K 4.1 February 24, 2023
−Removed: 4.10 Form of Pre-Funded Warrant.
−Removed: 8-K 4.1 October 31, 2023
−Removed: 4.11 Form of Common Warrant.
−Removed: 8-K 4.2 October 31, 2023
4.7 Form of Common Warrant issued in connection with January 2024 Offering.
10 unchanged sentences
8-K 4.2 August 1, 2024
−Removed: Number Description Form Exhibit Filing Date
4.13 Form of Pre-Funded Warrant.
2 unchanged sentences
8-K 4.2 January 29, 2025
+Added: 4.15 Form of Inducement Warrant
+Added: 8-K 4.1 September 11, 2025
+Added: 4.16 Form of Inducement Warrant
+Added: 8-K 4.1 October 27, 2025
9.1 Securities Purchase Agreement dated March 7, 2018 by and between the Registrant and certain investors.
6 unchanged sentences
8-K 10.10 January 5, 2018
−Removed: 10.4* 2017 Employee Stock Purchase Plan of the Registrant.
−Removed: 8-K 10.11 January 5, 2018
+Added: Number Description Form Exhibit Filing Date
10.4* Form of Stock Option Grant Notice and Option Agreement under the 2017 Equity Incentive Plan.
7 unchanged sentences
10.8* Letter Employment Agreement, effective as of January 2, 2020, by and between the Registrant and Dragan Cicic.
+Added: 10-K 10.9 March 20, 2025
10.9* Change in Control Severance Agreement, dated December 14, 2021, between SELLAS Life Sciences Group, Inc and Dragan Cicic, M.D.
−Removed: 8-K 10.1 December 16, 2021
+Added: 10.1 December 16, 2021
10.10* Amendment to Change in Control Severance Agreement, effective as of January 22, 2024, by and between the Registrant and Dragan Cicic.
+Added: 10-K 10.11 March 20, 2025
10.11* Amendment to Change in Control Severance Agreement, effective as of March 4, 2025, by and between the Registrant and Dragan Cicic.
+Added: 10-K 10.12 March 20, 2025
10.12* Amendment to Change in Control Severance Agreement, effective as of March 4, 2025, by and between the Registrant and John Burns.
+Added: 10-K 10.13 March 20, 2025
10.14+ Amended and Restated Exclusive License Agreement by and between SELLAS Life Sciences Group Ltd and Memorial Sloan Kettering Cancer Center, effective October 11, 2017.
2 unchanged sentences
8-K 10.8 January 5, 2018
−Removed: 10.28 Form of Warrant Exercise Agreement, dated March 6, 2019.
−Removed: 8-K 10.1 March 6, 2019
10.16* 2023 Amended and Restated Equity Incentive Plan.
12 unchanged sentences
10-K 10.36 March 31, 2022
−Removed: Number Description Form Exhibit Filing Date
10.23* 2021 Employee Stock Purchase Plan.
14 unchanged sentences
8-K 10.1 March 1, 2023
+Added: Number Description Form Exhibit Filing Date
10.30* 2023 Amended and Restated Equity Incentive Plan.
37 unchanged sentences
8-K 10.1 January 29, 2025
+Added: 10.46 Amended and Restated 2021 Employee Stock Purchase Plan
+Added: 10-Q 10.1 August 12, 2025
+Added: 10.47 Form of Inducement Agreement
+Added: 8-K 10.1 September 11, 2025
+Added: 10.48 Letter Agreement by and between SELLAS Life Sciences Group, Inc.
+Added: and Times Square Tower Associates LLC
+Added: 8-K 10.1 October 3, 2025
+Added: 10.49 Form of Inducement Agreement
+Added: 8-K 10.1 October 27, 2025
14.1 Code of Business Conduct and Ethics.
+Added: 10-K 14.1 March 20, 2025
19.1 Insider Trading Policy.
−Removed: Number Description Form Exhibit Filing Date
+Added: 10-K 19.1 March 20, 2025
21.1 Subsidiaries of the Registrant.
−Removed: 23.1 Consent of Moss Adams LLP, Independent Registered Public Accounting Firm.
+Added: 23.1 Consent of Baker Tilly US, LLP, Independent Registered Public Accounting Firm.
24.1 Powers of Attorney (included on signature page hereto).
31.1 Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities and Exchange Act, as amended.
+Added: Number Description Form Exhibit Filing Date
31.2 Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities and Exchange Act, as amended.
43 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.